These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 2779702
1. Vitamin D, desferrioxamine and aluminum-induced bone disease in uremic rats. Verbeelen D, Smeyers-Verbeke J, van Hooff I, de Roy G. Nephron; 1989; 53(1):54-60. PubMed ID: 2779702 [Abstract] [Full Text] [Related]
3. The effect of desferrioxamine on tissue aluminum concentration and bone histology in aluminum-loaded rats with renal failure. Verbeelen D, Smeyers-Verbeke J, van Hooff I, de Roy G. J Trace Elem Electrolytes Health Dis; 1988 Jun; 2(2):67-72. PubMed ID: 2980801 [Abstract] [Full Text] [Related]
4. The effect of desferrioxamine on concentration and distribution of aluminum in bone. Verbeelen D, Smeyers-Verbeke J, Van Hooff I, Van der Straeten A, De Roy G. Kidney Int; 1986 Jul; 30(1):68-73. PubMed ID: 3747345 [Abstract] [Full Text] [Related]
5. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ]. Jarava C, Armas JR, Palma A. Nefrologia; 2001 Jul; 21(2):174-81. PubMed ID: 11464651 [Abstract] [Full Text] [Related]
10. [Histological classification of uremic bone disease and clinical significance of bone biopsy]. Zhu JM, Alfrey AC, Huffer WE. Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):444-7. PubMed ID: 8275820 [Abstract] [Full Text] [Related]
16. The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia. Fournier A, Fohrer P, Leflon P, Moriniere P, Tolani M, Lambrey G, Demontis R, Sebert JL, Van Devyver F, Debroe M. Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Oct; 21():371-6. PubMed ID: 3991525 [Abstract] [Full Text] [Related]
17. Ultrastructural evaluation of the effects of vitamin D and uremia on bone in the rat. Weisbrode SE, Capen CC, Nagode LA. Am J Pathol; 1974 Aug; 76(2):359-76. PubMed ID: 4276472 [Abstract] [Full Text] [Related]
18. Studies the alterations of biochemical and mineral contents in bone tissue of mus musculus due to aluminum toxicity and the protective action of desferrioxamine and deferiprone by FTIR, ICP-OES, SEM and XRD techniques. Sivakumar S, Khatiwada CP, Sivasubramanian J. Spectrochim Acta A Mol Biomol Spectrosc; 2014 May 21; 126():59-67. PubMed ID: 24583473 [Abstract] [Full Text] [Related]
20. Clinical features of aluminum-associated bone disease in long-term hemodialysis patients. Iwamoto N, Ono T, Yamazaki S, Fukuda T, Kondo M, Yamamoto N, Hiratake Y, Masugi Y, Kubo Y, Hino M. Nephron; 1986 May 21; 42(3):204-9. PubMed ID: 3945360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]